# Contact Safe Ipamorelin

> Contact Safe Ipamorelin, an independent editorial digest of the ipamorelin research literature. Editorial inquiries and corrections only; no medical advice, no products, no prescriptions.

Editorial inquiries, source suggestions, and corrections.

## Editorial inquiries and corrections

Safe Ipamorelin is an independent editorial digest of the ipamorelin research literature. Use the form below for editorial inquiries, to suggest a peer-reviewed study we should cover, or to flag a citation that needs correcting. Accuracy matters to us: if you believe a figure on this site misreads its source, tell us which page and which claim, and we will check it against the literature.

What we cannot help with: we do not provide medical or health advice, we do not recommend or supply ipamorelin or any other compound, and we do not offer consultations, prescriptions, or product sourcing. Questions about personal use should go to a qualified healthcare professional — this site is a reading desk for the published science, nothing more.

## Contact form

Send a message using the fields below. Please include the page title and the specific claim if your message concerns a correction, so we can trace it back to the source quickly.

---

A Carbon-plain reading of the ipamorelin record: the selective GH pulse and the ~2-hour human half-life logged where the studies confirm them, the failed Phase 2 trial and the blank long-term-safety line set in equal type, and the CJC-1295 stack read as class pharmacology rather than a tested product — the word 'safe' here naming a question we keep open, with no clinic behind the page and nothing dosed, compounded, prescribed, or sold.